Warning: This security is no longer trading.
Sanofi completes acquisition of Bioverativ
Bioverativ Inc. (BIVV): Price and Financial Metrics
BIVV Price/Volume Stats
| Current price | $104.98 | 52-week high | $105.01 |
| Prev. close | $104.65 | 52-week low | $48.14 |
| Day low | $104.97 | Volume | 792,900 |
| Day high | $105.01 | Avg. volume | 3,027,685 |
| 50-day MA | $88.36 | Dividend yield | N/A |
| 200-day MA | $64.81 | Market Cap | 11.36B |
BIVV Stock Price Chart Interactive Chart >
Bioverativ Inc. (BIVV) Company Bio
Bioverativ, a spin-off of Biogen’s hemophilia business, will be an independent, publicly-traded, global biotechnology company focused on the discovery, research, development and commercialization of therapies for hemophilia and other blood disorders.
BIVV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...